Lars Sävendahl
-
- Growth Hormone and Insulin-like Growth Factors 60
- Genetics top 1%
- Estrogen and related hormone effects 21
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 8
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms 7
- Nephrology top 2%
-
- Childhood Cancer Survivors' Quality of Life 18
- Birth, Development, and Health 13
-
- Sexual Differentiation and Disorders 10
- Bone Metabolism and Diseases 8
- Co-authors
- Andrei S. ChaginDionisios ChrysisE. Martin RitzénClaes OhlssonOla NilssonFarasat ZamanMarsha L. DavenportMasaharu Takigawa
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Lars Sävendahl
146 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Endocrinology, Diabetes and Metabolism 1.5k
- Genetics 1.7k
- Orthopedics and Sports Medicine 412
- Rheumatology 609
- Nephrology 259
Countries citing papers authored by Lars Sävendahl
This map shows the geographic impact of Lars Sävendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Sävendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Sävendahl more than expected).
Fields of papers citing papers by Lars Sävendahl
This network shows the impact of papers produced by Lars Sävendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Sävendahl. The network helps show where Lars Sävendahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Sävendahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 6 | |
| 9 | 2020 | 15 | |
| 10 | Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiabreakdown → | 2019 | 316 |
| 11 | Contribution of GHR and IGFALS Mutations to Growth Hormone Resistance - Identification of New Variants and Impact on the Inheritance Pattern | 2016 | 1 |
| 12 | A Novel Reversible Albumin-Binding GH Derivative Possesses a Promising Once-Weekly Treatment Profile in Children with GH Deficiency | 2015 | 0 |
| 13 | Positive Association between Height and Cancer in the Swedish Population | 2015 | 2 |
| 14 | 2013 | 39 | |
| 15 | 2011 | 14 | |
| 16 | 2010 | 9 | |
| 17 | 2010 | 27 | |
| 18 | 2007 | 28 | |
| 19 | 2003 | 104 | |
| 20 | 1997 | 40 |
About Lars Sävendahl
Lars Sävendahl is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pediatrics, Perinatology and Child Health, having authored 154 papers that have together received 4.9k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (60 papers), Estrogen and related hormone effects (21 papers), Childhood Cancer Survivors' Quality of Life (18 papers), Birth, Development, and Health (13 papers), Sexual Differentiation and Disorders (10 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (8 papers), Bone Metabolism and Diseases (8 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Genetics (1.7k citations) and Orthopedics and Sports Medicine (412 citations). Lars Sävendahl has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Andrei S. Chagin, Dionisios Chrysis, E. Martin Ritzén, Claes Ohlsson, Ola Nilsson, Farasat Zaman, Marsha L. Davenport, Masaharu Takigawa, Jan M. Wit and Louis E. Underwood. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.